This post was originally published on this site
https://i-invdn-com.investing.com/trkd-images/LYNXMPEJBC0WE_L.jpg
The system, PulseSelect Pulsed Field Ablation (PFA), is used for the treatment of atrial fibrillation (AF), a condition that is characterized by an irregular rhythm of the heart.
PFA is used for ablation procedures that treat AF using small burns or freezes to cause some scarring on the inside of the heart to help break up the electrical signals that cause irregular heartbeats.
Commercialization of the PFA system will start in early 2024, the company said.
